INNOVA CAPTAB
Back to Income Statement
|
INNOVA CAPTAB Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,244 Cr | ₹1,081 Cr | ₹926 Cr | ₹801 Cr | ₹411 Cr |
What is the latest Revenue of INNOVA CAPTAB ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,244 Cr |
| Mar2025 | ₹1,081 Cr |
| Mar2024 | ₹926 Cr |
| Mar2023 | ₹801 Cr |
| Mar2022 | ₹411 Cr |
How is Revenue of INNOVA CAPTAB Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,244 Cr | 15.02 | |
| Mar2025 | ₹1,081 Cr | 16.72 | |
| Mar2024 | ₹926 Cr | 15.72 | |
| Mar2023 | ₹801 Cr | 94.94 | |
| Mar2022 | ₹411 Cr | - | |
Compare Revenue of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹5,484.9 Cr | -1.6% | -2.3% | 2.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -1.6% |
-2.3% |
2.7% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses